A compound developed to treat leukemia could be effective in the prevention of asthma.
Researchers found that the new compound activates a protein that is suppressed during asthma, which means in future doctors could treat the cause of asthma attacks rather than just the symptoms.
Researchers have begun testing therapeutic strategies to modify the pathway of asthma development and hope to inhibit the pathway to protect against both virus- and allergen-induced asthma.
Read more at UNSW